Commento dell’articolo: Ferrari S, Hars M, Biver E, Uebelhart B, Joly AC, Herrmann F, Meier C, Lippuner K. Preventing post-denosumab bone loss with zoledronate: a 2-year randomized trial in post-menopausal women without and with pre-exposure to bisphosphonates....
Commento a Lee, J., Lee, GR., Lee, H.I. et al. Rgnef regulates bone mass through the activation of RhoA and Rac1. Exp Mol Med 58, 243–253 (2026). https://doi.org/10.1038/s12276-025-01631-w Figura da https://doi.org/10.1038/s12276-025-01631-w La caratterizzazione dei...
Visita il sito Vai ai Congressi Nazionali SIOMMMS
